Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Vitamin D reduced the expression of inflammatory and apoptotic factors induced by propofol, such as TNF-α (group P versus group PD: 0.79 (0.76 to 0.81) versus 0.36 (0.34 to 0.39), %95 CI; p < 0.001), Bax (group P versus group PD: 0.72 (0.69 to 0.74) versus 0.52 (0.5 to 0.54), %95 CI; p < 0.001) in the hippocampus in PN7.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Animal research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Twenty pregnant mice were randomly divided into four groups.
Source: Abstract.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D alleviates neurotoxicity induced by propofol anaesthesia in the offspring of mice
Study design awaiting verification · PLOS One · 2026
Original publication title
Vitamin D alleviates neurotoxicity induced by propofol anaesthesia in the offspring of mice
© 2026 Solmaz et al
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Maternal propofol can induce neurotoxicity in the developing brain. Vitamin D modulates neurotrophin and neuromediator synthesis, reduces neuroinflammation and neuroapoptosis. The present study examined whether vitamin D could mitigate maternal propofol induced neurotoxicity in the offspring.
Source: BackgroundAbstract: What methods does the paper describe?
Twenty pregnant mice were randomly divided into four groups. During the pregnancy, the groups designated as D and PD were given intraperitoneal vitamin D, while the groups labelled as P and C received 1 ml of saline. On the 14th day of pregnancy, groups P and PD received 200 mg kg-1 of propofol intraperitoneally. Newborn mice from the aforementioned groups were included in the study. The hippocampus and the prefrontal cortex were examined by immunohistochemistry at two postnatal ages: 7 and 45 days (PN7 and PN45).
A battery of behavioural assessments was conducted using open field and elevated plus maze tests to evaluate potential alterations at PN45.
Source: MethodAbstract: Results
Vitamin D reduced the expression of inflammatory and apoptotic factors induced by propofol, such as TNF-α (group P versus group PD: 0.79 (0.76 to 0.81) versus 0.36 (0.34 to 0.39), %95 CI; p < 0.001), Bax (group P versus group PD: 0.72 (0.69 to 0.74) versus 0.52 (0.5 to 0.54), %95 CI; p < 0.001) in the hippocampus in PN7. The administration of vitamin D resulted in enhanced expression of anti-apoptotic and neuroprotective proteins, such as Bcl-2 (group P versus group PD: 0.3 (0.27 to 0.33) versus 0.55 (0.53 to 0.57), %95 CI; p < 0.001) in the hippocampus in PN7.
These changes also occurred in the hippocampus in PN45 and the prefrontal cortex in PN7 and PN45. No significant differences were identified in the behavioural tests between the groups.
Source: ResultsAbstract: Conclusion
Vitamin D treatment during pregnancy could prevent neurotoxicity in the offspring of mice exposed to propofol.
Source: ConclusionAuthors’ abstract
Background
Maternal propofol can induce neurotoxicity in the developing brain. Vitamin D modulates neurotrophin and neuromediator synthesis, reduces neuroinflammation and neuroapoptosis. The present study examined whether vitamin D could mitigate maternal propofol induced neurotoxicity in the offspring.
Method
Twenty pregnant mice were randomly divided into four groups. During the pregnancy, the groups designated as D and PD were given intraperitoneal vitamin D, while the groups labelled as P and C received 1 ml of saline. On the 14th day of pregnancy, groups P and PD received 200 mg kg-1 of propofol intraperitoneally. Newborn mice from the aforementioned groups were included in the study. The hippocampus and the prefrontal cortex were examined by immunohistochemistry at two postnatal ages: 7 and 45 days (PN7 and PN45).
A battery of behavioural assessments was conducted using open field and elevated plus maze tests to evaluate potential alterations at PN45.
Results
Vitamin D reduced the expression of inflammatory and apoptotic factors induced by propofol, such as TNF-α (group P versus group PD: 0.79 (0.76 to 0.81) versus 0.36 (0.34 to 0.39), %95 CI; p < 0.001), Bax (group P versus group PD: 0.72 (0.69 to 0.74) versus 0.52 (0.5 to 0.54), %95 CI; p < 0.001) in the hippocampus in PN7. The administration of vitamin D resulted in enhanced expression of anti-apoptotic and neuroprotective proteins, such as Bcl-2 (group P versus group PD: 0.3 (0.27 to 0.33) versus 0.55 (0.53 to 0.57), %95 CI; p < 0.001) in the hippocampus in PN7.
These changes also occurred in the hippocampus in PN45 and the prefrontal cortex in PN7 and PN45. No significant differences were identified in the behavioural tests between the groups.
Conclusion
Vitamin D treatment during pregnancy could prevent neurotoxicity in the offspring of mice exposed to propofol.
Publication and source details
Original title: Vitamin D alleviates neurotoxicity induced by propofol anaesthesia in the offspring of mice
Hüseyin Cihat Solmaz; Feride Karacaer; Ebru Biricik; Demet Tunay; Müge Can; Samet Kara; Kübra Akıllıoğlu; Sait Polat
PLOS One · 2026
Competing Interests: The authors have declared that no competing interests exist.
Current adress: Uludağ University Hospital, Anesthesiology and Reanimation Department, Bursa, Turkiye
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T10:31:01.596043+00:00
DOI: 10.1371/journal.pone.0349784 · PMC13196955